Please complete the CAPTCHA to continue
@amgen.com
✓
3 phones found area 609 and 212
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Daniel Freeman is listed as Vice President, Early Development Oncology at AstraZeneca at AstraZeneca, based in Washington DC-Baltimore Area, United States, United States. AeroLeads shows a work email signal at amgen.com, phone signal with area code 609, 212, and a matched LinkedIn profile for Daniel Freeman.
Daniel Freeman previously worked as Vice President, Early Development Oncology at Astrazeneca and Head of Next Generation Oncology Development at Medimmune. Daniel Freeman holds Phd, Molecular And Medical Pharmacology from Ucla.
This section adds company-level context without repeating Daniel Freeman's masked contact details.
AeroLeads found 1 current-domain work email signal for Daniel Freeman. Compare company email patterns before reaching out.
As Vice President in Oncology R&D at AstraZeneca, I lead the early Oncology Projects group, which is responsible for developing our portfolio of oncology medicines, from preclinical evaluation to Phase 3 enabling clinical trials.I am committed to seeking out the best science and attracting the best scientific partners, and since joining AstraZeneca in 2016 I have led numerous internal programmes and external collaborations. Building on the breadth of experience, I have helped shape the early oncology development strategy, and contributed to business development and critical portfolio decisions. Testament to my passion for delivering results and bringing meaningful medicines to patients, in 2021 the scope of my role expanded from leading the large molecule portfolio to leading AstraZeneca’s full early development project portfolio. Since then, the early Oncology Projects group has been instrumental in the successful transition of six new molecular entities from early to late development, spanning several of our scientific pillars.Prior to joining AstraZeneca, I held positions of increasing seniority at Bristol-Myers Squibb, Daiichi Sankyo and Amgen. Throughout my 25-year career, I have worked on a breadth of small molecule and antibody programmes within oncology, with a focus on biology, translational medicine and early development.During this time, I’ve enjoyed building multiple cross-functional discovery and development teams, bringing together colleagues with diverse backgrounds and experiences, with the goal to deliver robust portfolios with the greatest potential for producing effective cancer medicines. I’m particularly proud of having mentored colleagues as they have advanced their careers in the industry.I’ve authored more than 100 papers and conference abstracts about cancer research, and generated 10 patents to date.Outside of work, I enjoy being out in nature and cycling and spending time in my workshop building furniture. My expertise include: project strategy, IO, ADCs, cell therapy, oncology research, biomarkers
Listed skills include Biomarkers, Clinical Development, Drug Development, Oncology, and 18 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Cambridge, Cambridgeshire, GB
Oversee a world-class Oncology R&D project team in the development of immunotherapy, ADCs, radio conjugates, cell therapy, t-cell engagers, epigenetics, tumour drivers and resistance, and DNA damage response agents from early discovery to phase 3 development. With accountability for strategy on both asset and portfolio level, the team has been instrumental.
Gaithersburg, Maryland, US
Responsible for leading cross-functional teams to deliver programs from candidate selection through to clinical proof of concept. Modalities included novel bispecifics, priming agents, oncolytic viruses and next generation checkpoint inhibitors.
Lawrence Township, NJ, US
Head of the oncology biomarker group and chair of the oncology translational research and development committee. Led a group of PhD scientists to develop and deliver a biomarker strategy for the oncology pipeline across stages of clinical development, with a critical contribution to enabling biomarker selection and personalized medicine approaches.
Basking Ridge, NJ, US
Head of the biomarker group, accountable for the discovery and development of biomarkers for several therapeutic areas. Successfully led the incorporation of novel biomarkers, including exploratory and companion diagnostic assays, into all stages of clinical development.
Basking Ridge, NJ, US
Part of a cross functional team which managed the oncology portfolio, integrating the scientific, translational and clinical opportunities. Key achievements included leading clinical sub teams to define clinical development strategies, and due diligence on multiple licensing opportunities.
Thousand Oaks, CA, US
Led a group of preclinical scientists responsible for the discovery of a new oncology target, and the discovery of the first negative selection biomarker in oncology (KRAS for EGFR antibodies). The biomarker is still in use as critical factor in determining treatment decisions for patients with colorectal cancer.
Quick answers generated from the profile data available on this page.
Daniel Freeman works for AstraZeneca.
Daniel Freeman is listed as Vice President, Early Development Oncology at AstraZeneca at AstraZeneca.
AeroLeads has found 1 work email signal at @amgen.com for Daniel Freeman at AstraZeneca.
AeroLeads has found 3 phone signal(s) with area code 609, 212 for Daniel Freeman at AstraZeneca.
Daniel Freeman is based in Washington DC-Baltimore Area, United States, United States while working with AstraZeneca.
Daniel Freeman has worked for Astrazeneca, Medimmune, Bristol-Myers Squibb, Daiichi Sankyo, and Amgen.
You can use AeroLeads to view verified contact signals for Daniel Freeman at AstraZeneca, including work email, phone, and LinkedIn data when available.
Daniel Freeman holds Phd, Molecular And Medical Pharmacology from Ucla.
Daniel Freeman is listed with skills including Biomarkers, Clinical Development, Drug Development, Oncology, Translational Medicine, Life Sciences, Biotechnology, and Clinical Research.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts